Stockscreener 앱 받기
0.2559
1.77%
-0.0046
시간 외 거래:
.28
0.0241
+9.42%
Fibrobiologics Inc 주식(FBLG)의 최신 뉴스
FibroBiologics, Inc. 2025 Executive Compensation and Leadership Overview - Minichart
FibroBiologics (NASDAQ: FBLG) adds 2025 governance, pay and ownership details - Stock Titan
FibroBiologics: CYWC628 Drives Buy Rating on Strong Preclinical Wound and Burn Data in Large Underserved Markets - TipRanks
D. Boral Capital Reiterates 'Buy' Rating for FibroBiologics - National Today
FibroBiologics Announces Advances in Burn Treatment Using Proprietary Fibroblast Spheroid Technology - Bitget
Experimental cell-based treatment aims to speed healing for severe burns - Stock Titan
Gainers Report: Is FibroBiologics Inc benefiting from interest rate changesQuarterly Portfolio Summary & Safe Capital Growth Trade Ideas - baoquankhu1.vn
FibroBiologics Updates CFO Compensation to Support Leadership - TipRanks
FibroBiologics sets new annual salary for CFO Jason D. Davis - Investing.com
FibroBiologics sets new annual salary for CFO Jason D. Davis By Investing.com - Investing.com Canada
FibroBiologics Completes Site Onboarding for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers - Sahm
FibroBiologics completes site onboarding for diabetic ulcer trial By Investing.com - Investing.com Canada
Top Executive Makes Bold Move Into FibroBiologics Stock - TipRanks
FibroBiologics completes site onboarding for diabetic ulcer trial - Investing.com
FibroBiologics (FBLG) CSO Khoja buys $11k in stock - Investing.com
FibroBiologics (FBLG) CSO Khoja buys $11k in stock By Investing.com - Investing.com Australia
FibroBiologics Completes Site Onboarding for Phase 1/2 - GlobeNewswire
CEO Doubles Down on FibroBiologics With Bold Insider Stock Purchase - TipRanks
FBLG Earnings History & Surprises | EPS & Revenue Results | FIBROBIOLOGICS INC (NASDAQ:FBLG) - ChartMill
FibroBiologics CFO Buys 70,000 Shares - National Today
CFO’s Bold Insider Buy Sparks Fresh Buzz Around FibroBiologics Stock - TipRanks
Davis Jason, FibroBiologics CFO, buys $28973 in FBLG stock By Investing.com - Investing.com Australia
Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them - Benzinga
Davis Jason, FibroBiologics CFO, buys $28973 in FBLG stock - Investing.com
FibroBiologics (FBLG) CFO purchases 70,000 shares in open-market trade - Stock Titan
FibroBiologics receives patent for osteoporosis cell therapy By Investing.com - Investing.com Canada
Insider Makes Bold New Bet on FibroBiologics Stock - TipRanks
FBLG Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
FibroBiologics Jumps 22% On New Osteoporosis Patent, Stock Up - Nasdaq
Garcia Ruben A, FibroBiologics general counsel, buys $13k in FBLG - Investing.com Australia
FibroBiologics receives patent for osteoporosis cell therapy - Investing.com
FibroBiologics, Inc. announces issuance of U.S. patent covering fibroblast cell therapy for the treatment of osteoporosis - marketscreener.com
Fibrobiologics, Inc. Announces Issuance Of U.S. Patent Covering Fibroblast Cell Therapy For The Treatment Of Osteoporosis - TradingView
FibroBiologics, Inc. Announces Issuance of U.S. Patent - GlobeNewswire
FibroBiologics, Inc. Announces Issuance of U.S. Patent Covering Fibroblast Cell Therapy for the Treatment of Osteoporosis - Bitget
FBLG: Ready to Transition to Clinical-Stage Company - Smartkarma
FibroBiologics to Present at the BIO Investment & Growth Summit - Bitget
H.C. Wainwright cuts FibroBiologics stock price target to $4 By Investing.com - Investing.com Canada
H.C. Wainwright cuts FibroBiologics stock price target to $4 - Investing.com Nigeria
FibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update - Bitget
1.20%
0.06%
자본화:
|
볼륨(24시간):